CRHR1 and Anxiety: Antalarmin has also been shown to reduce fear conditioning responses in rats defined as “high anxiety” (Skórzewska et al., 2019), while both oral administration and intra-amygdalar infusions of the selective CRF1 antagonist DMP696 reduced contextual freezing with no effect on fear acquisition (Hubbard et al., 2007).